Xcout IntelSign inSubscribe

Zota Health Care LImited competitors & alternatives

ZOTAPharmaceuticalsSurat, India

The 12 closest competitors and alternatives to Zota Health Care LImited among pharmaceuticals companies — ranked by similarity to what Zota Health Care LImited actually does, not by market-cap band.

$352.6MMarket cap
445Employees
12Competitors listed

Subscribe to see Zota Health Care LImited’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Zota Health Care LImited

Zota Health Care Limited is an Indian pharmaceutical firm dedicated to the development, manufacturing, and distribution of a broad spectrum of health-related products across India. Its extensive portfolio encompasses generic medications, over-the-counter (OTC) remedies, traditional Ayurvedic formulations, and nutritional supplements (nutraceuticals). The company places a particular emphasis on supplying treatments for various long-term illnesses, including but not limited to heart disease, diabetes, and thyroid conditions. By March 31, 2021, Zota had established a considerable retail network, operating 591 stores under its DAVAINDIA brand name throughout 24 states in India. The company was founded in 1995 and is currently headquartered in Surat, India.

Zota Health Care LImited at a glance

Zota Health Care LImited is a pharmaceuticals company headquartered in Surat, India. It is publicly listed (ZOTA) with a market capitalisation of $352.6M. Xcout tracks 13 named people at Zota Health Care LImited, including Sujit Paul (Chief Executive Officer and Key Managerial Personnel).

Zota Health Care LImited leadership

  • Sujit PaulChief Executive Officer and Key Managerial Personnel
  • Moxesh Ketanbhai ZotaManaging Director
  • Ketankumar Chandulal ZotaChairman
  • Himanshu Muktilal ZotaWhole Time Director
  • Kamlesh Rajanikant ZotaWhole Time Director
  • Viren Manukant ZotaWhole Time Director

7 more named people on record for Zota Health Care LImited, with roles, board committees and tenure — see the full roster →

Top 12 Zota Health Care LImited competitors

Ranked by semantic similarity — how close each company is to Zota Health Care LImited by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

ゼリア新薬工業4559 · PharmaceuticalsTokyo, Japan
62% matchPublic

Similar pharmaceuticals company

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn’s disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia, and iron deficiency anemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; and non-steroidal anti-inflammatory ophthalmic solutions. In addition, it provides consumer healthcare products, such as nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses. Further, the company engages in insurance agency and real estate business. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was incorporated in 1955 and is headquartered in Tokyo, Japan.

Market cap$579.8M
Employees1,748
ゼリア新薬工業 competitors & alternatives →
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED600329 · PharmaceuticalsTianjin, China
61% matchPublic

Similar pharmaceuticals company

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.

Market cap$3.1B
Employees3,890
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED competitors & alternatives →
JACOBSON PHARMA02633 · PharmaceuticalsKwun Tong, Hong Kong
61% matchPublic

Similar pharmaceuticals company

Jacobson Pharma Corporation Limited, a subsidiary of Kingshill Development Limited, specializes in the production, promotion, and distribution of generic medications and branded healthcare products. Its market reach extends across Hong Kong, mainland China, Macau, Singapore, and international territories. The company offers a broad selection of generic pharmaceuticals targeting diverse medical conditions, including respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergic, scar treatment, oral anti-diabetic, and anti-infective categories. Specific examples comprise arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. In addition to generics, the company provides branded medications, health and wellness products, and traditional Chinese remedies. Prominent proprietary Chinese medicines include Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. Its operations also extend to trading medical provisions, procuring packaging materials, distributing herbal and health-related goods, conducting research and development, and managing property holdings. The company distributes its offerings to a wide range of clients, including hospitals, clinics, authorized pharmacies, independent physicians, retail outlets, and trading companies. Founded in 2016, Jacobson Pharma Corporation Limited is headquartered in Kwun Tong, Hong Kong.

Market cap$263.8M
Employees1,768
JACOBSON PHARMA competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Zota Health Care LImited and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Zota Health Care LImitedand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →